Biogen would like to make additional biotech acquisitions in 2025 beyond Friday’s offer to buy its financially troubled partner Sage Therapeutics, chief executive Chris Viehbacher told STAT’s Adam Feuerstein. “We will be doing deals — the size of those deals, I cannot say,” he said in an interview ahead of the J.P. Morgan Healthcare Conference.
Read the full article: Biogen CEO Confirms He’s Shopping for Biotechs: ‘We Will Be Doing Deals’ //
Source: https://www.statnews.com/2025/01/12/jpm-biogen-chris-viehbacher-sage-deals/